Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities

Antiretroviral therapy adherence and retention in care in middle-income and low-income... Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities a,b c d Jean B. Nachega , Edward J. Mills and Mauro Schechter Harvard School of Public Health, Boston, Purpose of review Massachusetts, USA, Stellenbosch University, Adherence to combination antiretroviral therapy (cART) is one of the most important Department of Medicine and Center for Infectious Diseases, Cape Town, South Africa, Center for contributing factors to positive clinical outcomes in patients with HIV, and long-term Excellence in HIV/AIDS, University of British Columbia retention of patients in low-income and middle-income countries is emerging as an & Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada and Projeto Prac ¸a Onze, important issue in rapidly expanding cART programs. This review presents recent Universidade Federal do Rio de Janeiro, Rio de developments in both treatment adherence and retention of patients in low-income and Janeiro, Brazil middle-income countries. Correspondence to Jean B. Nachega, MD, PhD, Recent findings Harvard School of Public Health, 655 Huntington Avenue, Room 437C, Boston, MA 02115, USA Adherence is among the most modifiable variables in treatment, but there still is no ‘gold Tel: +1 617 432 4110; fax: +1 617 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities

Current Opinion in HIV and Aids , Volume 5 (1) – Jan 1, 2010

Loading next page...
 
/lp/wolters-kluwer-health/antiretroviral-therapy-adherence-and-retention-in-care-in-middle-pepj6Qm0A5

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0b013e328333ad61
pmid
20046150
Publisher site
See Article on Publisher Site

Abstract

Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities a,b c d Jean B. Nachega , Edward J. Mills and Mauro Schechter Harvard School of Public Health, Boston, Purpose of review Massachusetts, USA, Stellenbosch University, Adherence to combination antiretroviral therapy (cART) is one of the most important Department of Medicine and Center for Infectious Diseases, Cape Town, South Africa, Center for contributing factors to positive clinical outcomes in patients with HIV, and long-term Excellence in HIV/AIDS, University of British Columbia retention of patients in low-income and middle-income countries is emerging as an & Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada and Projeto Prac ¸a Onze, important issue in rapidly expanding cART programs. This review presents recent Universidade Federal do Rio de Janeiro, Rio de developments in both treatment adherence and retention of patients in low-income and Janeiro, Brazil middle-income countries. Correspondence to Jean B. Nachega, MD, PhD, Recent findings Harvard School of Public Health, 655 Huntington Avenue, Room 437C, Boston, MA 02115, USA Adherence is among the most modifiable variables in treatment, but there still is no ‘gold Tel: +1 617 432 4110; fax: +1 617

Journal

Current Opinion in HIV and AidsWolters Kluwer Health

Published: Jan 1, 2010

There are no references for this article.